Drug Type AAV based gene therapy |
Synonyms IVB 107, IVB107, PUMCH-E101 + [1] |
Target |
Action modulators |
Mechanism RDH12 modulators(retinol dehydrogenase 12 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhaseEarly Phase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetic Retinopathy | Phase 1 | China | 20 Sep 2024 | |
Retinitis Pigmentosa | Phase 1 | China | 20 Sep 2024 |